CD42b
Aliases: | BDPLT1, BDPLT3, BSS, CD42B, CD42b-alpha, DBPLT3, GP1B, GPIbA, GPIbalpha, VWDP |
---|---|
Other: | platelet glycoprotein Ib alpha chain|GP-Ib alpha|antigen CD42b-alpha|glycoprotein Ib (platelet), alpha polypeptide|glycoprotein Ib platelet alpha subunit|mutant platelet membrane glycoprotein Ib-alpha|platelet membrane glycoprotein 1b-alpha subunit|platelet membrane glycoprotein Ib-alpha |
Glycoprotein Ib (GP Ib) is a platelet surface membrane glycoprotein composed of a heterodimer, an alpha chain and a beta chain, that is linked by disulfide bonds. The Gp Ib functions as a receptor for von Willebrand factor (VWF). The complete receptor complex includes noncovalent association of the alpha and beta subunits with platelet glycoprotein IX and platelet glycoprotein V. The binding of... see more
Brilliant Violet 650
Common Laser: | 405 |
---|---|
Common Filter: | 660/20 |
Excitation Peak: | 405 |
Emission Peak: | 645 |
Brilliant™ Violet 650 (BV650) is a red-emitting tandem fluorophore that can be excited by the 405 nm Violet laser and collected using a 660/20 bandpass filter. BV650 has an excitation peak at 405 nm and an emission peak at 645 nm. Due to its unique Stokes shift, not many dyes have identical excitation and emission spectrums, but the nearest alternatives include SuperBright 645, Qdot® 655 and eF... see more
Popular CD42b Brilliant Violet 650 Antibodies
Company / SKU |
Applications | Marker / Reactivity |
Host / Isotype / Clone |
Size / Price |
Details | |
---|---|---|---|---|---|---|
BD Biosciences 740576 |
FC | CD42b Human |
Mouse IgG1 κ HIP1 |
50 μg $495 |
Details | |
Sony 2119625 |
FC | CD42b Human,Chimpanzee |
Mouse IgG1 κ HIP1 |
25 Tests $185 |
Details | |
BioLegend 303925 |
FC | CD42b Human,Chimpanzee |
Mouse IgG1 κ HIP1 |
25 Tests $176 |
Details | |
Sony 2119630 |
FC | CD42b Human,Chimpanzee |
Mouse IgG1 κ HIP1 |
100 Tests $451 |
Details | |
BioLegend 303926 |
FC | CD42b Human,Chimpanzee |
Mouse IgG1 κ HIP1 |
100 Tests $429 |
Details | |
Browse CD42b / Brilliant Violet 650 antibodies. |